Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Sherman Oaks. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Sherman Oaks at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
Multicenter, randomized, double-blind, placebo-controlled, parallel arm clinical study designed to evaluate the efficacy and safety of eblasakimab in participants with moderate-to-severe atopic dermatitis (AD) previously treated with dupilumab.The study consists of a 16-week treatment period and an 8-week follow-up period up to Week 24. Eligible participants will be randomized into one of the 2 treatment arms.
Sponsor: ASLAN Pharmaceuticals
Check if you qualify for this atopic dermatitis clinical trial in Sherman Oaks, CA
If you're searching for atopic dermatitis treatment options in Sherman Oaks, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sherman Oaks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.